Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lurasidone
Drug ID BADD_D01330
Description Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval for the treatment of bipolar disorder in the United States.
Indications and Usage Treatment of schizophrenia.
Marketing Status Prescription
ATC Code N05AE05
DrugBank ID DB08815
KEGG ID D04820
MeSH ID D000069056
PubChem ID 213046
TTD Drug ID D01QGX
NDC Product Code 50370-0036
Synonyms Lurasidone Hydrochloride | Hydrochloride, Lurasidone | Lurasidone HCl | HCl, Lurasidone | SM 13496 | 13496, SM | SM13496 | SM-13,496 | SM 13,496 | SM13,496 | SM-13496 | Lurasidone | N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide | Latuda
Chemical Information
Molecular Formula C28H36N4O2S
CAS Registry Number 367514-87-2
SMILES C1CCC(C(C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal pain07.01.05.002--
Abdominal pain upper07.01.05.003--
Abnormal dreams19.02.03.001; 17.15.02.001--Not Available
Abortion spontaneous18.01.04.0010.002389%Not Available
Affective disorder19.04.04.0010.001592%Not Available
Aggression19.05.01.0010.004777%Not Available
Agitation19.06.02.001; 17.02.05.0120.008759%
Agranulocytosis01.02.03.0010.001592%Not Available
Akathisia19.06.02.006; 17.01.02.0020.010351%
Alanine aminotransferase increased13.03.01.003--
Alopecia23.02.02.0010.004777%
Amenorrhoea21.01.02.001; 05.05.01.0020.002389%
Amnesia19.20.01.001; 17.03.02.0010.001592%
Anaemia01.03.02.001--
Anaphylactic reaction10.01.07.001; 24.06.03.0060.005574%
Anger19.04.02.0010.007962%Not Available
Angina pectoris02.02.02.002; 24.04.04.002--
Angioedema23.04.01.001; 10.01.05.0090.005574%Not Available
Anxiety19.06.02.0020.016721%
Apathy19.04.04.0020.001592%Not Available
Arrhythmia02.03.02.0010.001592%Not Available
Asthenia08.01.01.001--Not Available
Atrial fibrillation02.03.03.002--
Atrioventricular block02.03.01.002--Not Available
Atrioventricular block first degree02.03.01.004--
Back pain15.03.04.005--
Blister23.03.01.001; 12.01.06.0020.001592%Not Available
Blood creatine phosphokinase increased13.04.01.0010.002389%
Blood creatinine increased13.13.01.0040.004777%
The 1th Page    1 2 3 4 5    Next   Last    Total 9 Pages